Clinical trial

Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons

NCT00631566

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-05-01

PhaseNA

Study timeline

Study start (unknown)2007-05-01Date precision: month

Registry last updated2023-03-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Staphylococcal Infectionsunresolved

Interventions

Mupirocin (Bactroban) 2%; hexachlorophene (pHisoHex) 3%DRUG

Sponsors & collaborators

Henry M. Jackson Foundation for the Advancement of Military Medicinelead sponsor

Infectious Diseases Clinical Research Programcollaborator

National Institute of Allergy and Infectious Diseases (NIAID)collaborator

US Military HIV Research Programcollaborator

Mapped research locations

San AntonioTexas, United States1 San DiegoCalifornia, United States1 BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00631566 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.